Lactoferrin is a glycoprotein naturally present in milk, and Japan has one of the most developed lactoferrin ingredient and research bases in the world, built largely around the country’s dairy industry. Brands abroad ask for a Japan-made lactoferrin product because of that depth of formulation and trial experience.
This guide is for brand owners planning a lactoferrin product made in Japan. It covers what the human trials show, who funded them, why the delivery format matters more for this ingredient than for most, Japan’s regulatory framing, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a lactoferrin product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Japanese trials report reduced visceral fat area with enteric-coated lactoferrin, and improved everyday respiratory and systemic symptom scores in healthy adults, with several trials funded by the dairy companies that supplied the material.
| Study | Design | Reported result |
|---|---|---|
| Double-blind, placebo-controlled trial, British Journal of Nutrition 2010 (PMID 20691130) | 26 Japanese adults aged 22–60 with abdominal obesity; 300 mg/day enteric-coated bovine lactoferrin or placebo for 8 weeks | Visceral fat area decreased 14.6 cm² with lactoferrin versus 1.8 cm² with placebo (p = 0.009); body weight, BMI and hip circumference also decreased more with lactoferrin; conducted at the research headquarters of the company supplying the material |
| Randomised, double-blind, placebo-controlled trial, Nutrients 2023 (PMID 37764743) | 145 healthy adults (68 lactoferrin, 77 placebo); 200 mg/day bovine lactoferrin for 12 weeks | Combined respiratory and systemic symptom scores were significantly lower with lactoferrin during the intervention; markers of dendritic cell activity (CD86, HLA-DR) were significantly higher at 12 weeks; no adverse reactions reported; half the authors were employees of the dairy company that funded the study and supplied the test food |
Three points to keep in view:
- Size. The visceral fat trial studied only 26 people over 8 weeks. The immune-measure trial is larger at 145 people over 12 weeks, but both are short relative to how visceral fat and immune resilience change over months or years.
- Funding. Both trials were funded by, and partly authored by employees of, the dairy company that supplied the lactoferrin. That does not make the results wrong, but it is a material fact to disclose alongside any figure you cite.
- What was measured. “Everyday respiratory and systemic symptom scores” and “visceral fat area” are specific, narrow measures — not general immunity or general weight loss.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Lactoferrin appears in Japan’s Foods with Function Claims system, with notified products addressing categories such as visceral fat and BMI.
Under the Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind its stated function and submits it to the Consumer Affairs Agency before sale. Lactoferrin products have been notified in the visceral-fat and BMI categories, generally reflecting the kind of trial evidence above.
Two lessons for a brand abroad:
- A Japanese notification covers one specific, worded function at one tested amount. It is not a general licence to make broader weight-loss or immunity claims for the ingredient.
- A Japanese notification is not a global endorsement. It is a Japanese regulatory mechanism for products sold in Japan. Your label abroad follows your own market’s rules.
💬 Need an evidence summary for your regulatory adviser that separates Japanese notifications from the underlying trials? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe lactoferrin by the specific measures the trials found significant, never as a general weight-loss or immune-boosting ingredient.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for visceral fat area in a Japanese trial" | "Burns fat”, “boosts immunity”, or any disease name |
| ”Contains 200–300 mg enteric-coated lactoferrin per daily serving" | "Clinically proven” without naming the study, its funding and its limits |
| ”Studied for everyday respiratory and systemic wellbeing” | Implying protection from any named infection or illness |
How lactoferrin is formulated
Lactoferrin is a protein that stomach acid breaks down before it can act, so enteric coating is central to the specification — not an optional upgrade.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Enteric-coated hard capsule | Protects lactoferrin from stomach acid until it reaches the intestine, matching how it was tested in the trials above | Coating adds cost and manufacturing steps |
| Enteric-coated tablet | Similar protection in a smaller unit | Coating uniformity across the batch |
Decisions that shape the specification:
- Enteric coating. Both trials above used enteric-coated lactoferrin. An uncoated lactoferrin product is a different specification from what the evidence supports, and stomach acid degrades unprotected lactoferrin before it reaches the intestine.
- Source. Lactoferrin for foods is derived from bovine milk. Confirm the supplier’s purification method and purity.
- Amount per serving. Match the amount to a study you intend to cite — 200 mg/day and 300 mg/day both appear above.
- Milk allergen labelling. Lactoferrin is a milk-derived protein. Allergen labelling requirements for milk apply in most markets and must be confirmed for each one you sell in.
- Companion ingredients. Lactoferrin is sometimes combined with other ageing- or immune-focused ingredients. Each needs its own check against Japanese food law.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Bovine lactoferrin is a well-established food ingredient in Japan with existing Foods with Function Claims notifications. Companion botanicals in a combined formula need their own check, since some botanicals sold freely elsewhere are treated as medicines in Japan. See the Japan-made supplement OEM page, and compare with our lactic acid bacteria and NMN guides if you are building a combined formula.
Before you ask for a quotation
A factory can quote accurately once the source, the coating, the amount and the packaging are fixed.
- Lactoferrin source, purity and certificate of analysis
- Enteric coating specification
- Amount per serving and servings per pack
- Dosage form
- Milk allergen labelling for each market you sell in
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made lactoferrin product? Send us the concept — source, amount, form and the countries you will sell in.
Frequently asked questions
1. Does lactoferrin reduce visceral fat?
A 2010 Japanese trial in 26 adults with abdominal obesity found enteric-coated lactoferrin at 300 mg/day reduced visceral fat area significantly more than placebo over 8 weeks. It is a small, short, industry-funded trial in a specific population, so describe it as studied for visceral fat area, not as a general fat-loss product.
2. Does lactoferrin support everyday immune health?
A 2023 trial in 145 healthy adults found lower combined respiratory and systemic symptom scores and higher markers of dendritic cell activity with 200 mg/day lactoferrin over 12 weeks. Describe it by that specific, studied outcome.
3. Why does lactoferrin need enteric coating?
Lactoferrin is a protein, and stomach acid breaks it down before it can reach the intestine intact. Both trials cited here used enteric-coated lactoferrin, which is why the specification matters as much as the dose.
4. Is lactoferrin a milk allergen?
Yes. Lactoferrin is derived from bovine milk and needs milk allergen labelling in most markets. Confirm the requirement for each country you plan to sell in.
5. Is lactoferrin permitted in foods in Japan?
Yes. Bovine lactoferrin is a well-established Japanese food ingredient, with existing Foods with Function Claims notifications in categories such as visceral fat and BMI.
Sources: “Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets”, British Journal of Nutrition 2010, 104(11):1688-1695 (PMID 20691130); “Effects of Bovine Lactoferrin on the Maintenance of Respiratory and Systemic Physical Conditions in Healthy Adults”, Nutrients 2023, 15(18):3959 (PMID 37764743); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.